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he role of dense core secretory vesicles in the control
 
of cytosolic-free Ca
 
2
 
 
 
 concentrations ([Ca
 
2
 
 
 
]
 
c
 
) in
neuronal and neuroendocrine cells is enigmatic.
By constructing a vesicle-associated membrane protein
2–synaptobrevin.aequorin chimera, we show that in clonal
 
pancreatic islet 
 
β
 
-cells: (a) increases in [Ca
 
2
 
 
 
]
 
c
 
 cause a
prompt increase in intravesicular-free Ca
 
2
 
 
 
 concentration
 
([Ca
 
2
 
 
 
]
 
SV
 
), which is mediated by a P-type Ca
 
2
 
 
 
-ATPase distinct
from the sarco(endo) plasmic reticulum Ca
 
2
 
 
 
-ATPase, but
which may be related to the PMR1/ATP2C1 family of Ca
 
2
 
 
 
pumps; (b) steady state Ca
 
2
 
 
 
 concentrations are 3–5-fold
lower in secretory vesicles than in the endoplasmic reticulum
(ER) or Golgi apparatus, suggesting the existence of tightly
T
 
bound and more rapidly exchanging pools of Ca
 
2
 
 
 
; (c)
inositol (1,4,5) trisphosphate has no impact on [Ca
 
2
 
 
 
]
 
SV 
 
in
intact or permeabilized cells; and (d) ryanodine receptor
(RyR) activation with caffeine or 4-chloro-3-ethylphenol in
intact cells, or cyclic ADPribose in permeabilized cells,
causes a dramatic fall in [Ca
 
2
 
 
 
]
 
SV
 
. Thus, secretory vesicles
represent a dynamic Ca
 
2
 
 
 
 store in neuroendocrine cells,
whose characteristics are in part distinct from the ER/Golgi
apparatus. The presence of RyRs on secretory vesicles
suggests that local Ca
 
2
 
 
 
-induced Ca
 
2
 
 
 
 release from vesicles
 
docked at the plasma membrane could participate in
triggering exocytosis.
 
Introduction
 
In most mammalian cells, the ER (Streb et al., 1984; Rizzuto
et al., 1993; Brini et al., 1993) and Golgi complex (Pinton et
al., 1998) are believed to represent the major mobilizable
 
intracellular Ca
 
2
 
  
 
stores (Rutter et al., 1998). Uptake of Ca
 
2
 
 
 
into these stores is mediated largely by sarco(endo)plasmic
reticulum Ca
 
2
 
 
 
–ATPases (SERCAs)* (Moller et al., 1996)
and helps to maintain resting cytosolic Ca
 
2
 
 
 
 concentrations
 
([Ca
 
2
 
 
 
]
 
c
 
) at levels (
 
 
 
10
 
 
 
7
 
 M) some four orders of magnitude
lower than in the extracellular space (
 
 
 
10
 
 
 
3
 
 M). Release of
Ca
 
2
 
 
 
 from the ER and Golgi complex is provoked by hor-
mones and other agonists which generate inositol 1,4,5
trisphosphate (IP
 
3
 
) (Berridge, 1993) to open intracellular
receptors (Mikoshiba, 1997). In certain cell types, such as
skeletal muscle, these stores are also accessed by “Ca
 
2
 
 
 
-induced
Ca
 
2
 
 
 
 release”, via receptors for the insecticide, ryanodine (Lai
et al., 1988; Takeshima et al., 1989).
Secretory vesicles of both the dense core (Hellman et al.,
1976; Hutton et al., 1983) and small synaptic types (Andrews
and Reese, 1986) possess a substantial proportion of the to-
tal Ca
 
2
 
 
 
 in cells specialized for peptide secretion. However,
despite many studies, the role of secretory vesicles as Ca
 
2
 
 
 
buffers or stores remains controversial (Pozzan et al., 1994;
Rutter et al., 1998; Yoo, 2000).
Mobilization of dense core vesicle Ca
 
2
 
 
 
 by IP
 
3
 
 was origi-
nally suggested as a possibility in chromaffin cells (Yoo and
 
Albanesi, 1990). Later data suggested that IP
 
3
 
 receptors
may be present on the vesicle membrane in insulin-secreting
cells (Blondel et al., 1994), though subsequent experiments
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showed the antibody used cross-reacted with insulin (Ravaz-
zola et al., 1996). IP
 
3
 
, as well as the receptor (RyR) agonist
cyclic ADP ribose (cADPr) (Galione, 1994) have been re-
ported to release Ca
 
2
 
 
 
 from individual acinar cell zymogen
granules (Gerasimenko et al., 1996), although contamination
of these preparations (e.g., with ER or Golgi apparatus–
derived vesicles) is a potential problem (Yule et al., 1997). Fi-
nally, evidence for the direct participation of secretory gran-
ules in the control of cytoplasmic Ca
 
2
 
 
 
 concentration was
recently provided in intact goblet cells (Nguyen et al., 1998).
At present, the molecular mechanisms responsible for
Ca
 
2
 
 
 
 uptake into secretory vesicles are also a matter of con-
troversy. At high Ca
 
2
 
 
 
 concentrations (
 
 
 
50 
 
 
 
M), uptake
into dense core vesicles in permeabilized hypophysial cells
(Troadec et al., 1998; Thirion et al., 1999) and into isolated
chromaffin cell granules (Krieger-Brauer and Gratzl, 1982)
can occur via Na
 
 
 
/Ca
 
2
 
 
 
 exchange, while synaptic vesicles
also accumulate Ca
 
2
 
 
 
 via a Ca
 
2
 
 
 
-H
 
 
 
 antiport system (Gon-
calves et al., 1998). However, the pump/exchange mecha-
nisms active at physiological [Ca
 
2
 
 
 
]
 
c
 
 are uncertain.
To examine the pathways by which Ca
 
2
 
 
 
 crosses the limit-
ing membrane of the dense core secretory vesicle of living is-
let 
 
 
 
-cells, we have developed a new approach to monitor
the free Ca
 
2
 
 
 
 concentration within the secretory vesicle ma-
trix ([Ca
 
2
 
 
 
]
 
SV
 
) using recombinant targeted aequorin (Riz-
zuto et al., 1995). Cloned from the jellyfish 
 
Aequorea victo-
ria
 
 (Inouye et al., 1985), aequorin is a calcium-sensitive
bioluminescent protein (Cobbold and Rink, 1987), previ-
ously used to measure free Ca
 
2
 
 
 
 concentrations in a variety
of subcellular organelles (Rutter et al., 1998). Importantly,
aequorin activity is less severely inhibited at low pH values
(
 
 
 
6.5; Blinks, 1989) than Ca
 
2
 
 
 
 probes based on green fluo-
rescent protein (GFP) (Miyawaki et al., 1997; Baird et al.,
1999; Emmanouilidou et al., 1999). If appropriately tar-
geted, this probe should allow Ca
 
2
 
 
 
 concentrations to be
measured in the acidic environment of the secretory granule
interior (Orci et al., 1985).
Vesicle-associated membrane protein (VAMP)2/synapto-
brevin (Sudhof et al., 1989) is a vesicle-specific SNARE with
a single transmembrane-spanning region. Expression of chi-
maeric cDNA encoding a fusion protein between VAMP2
and aequorin (VAMP.Aq) has therefore allowed the intrave-
sicular-free Ca
 
2
 
 
 
 concentration to be monitored dynamically
in live MIN6 
 
 
 
-cells. With this approach, we show that Ca
 
2
 
 
 
is actively pumped into dense core vesicles when [Ca
 
2
 
 
 
]
 
c
 
 in-
creases, and may be released via RyR, but not IP
 
3
 
, receptors.
This release may be important at sites of high intracellular
Ca
 
2
 
 
 
, including sites of exocytosis at the plasma membrane.
 
Results
 
Subcellular targeting of recombinant VAMP.aequorin
 
Chimeric cDNA encoding hemagglutinin (HA)1-tagged ae-
quorin, fused to VAMP2 (Sudhof et al., 1989), was gener-
ated as shown in Fig. 1 A.
Immunocytochemical analysis of MIN6 cells transfected
with VAMP.Aq cDNA revealed close overlap with insulin
staining (Fig. 1 B). Explored at a higher resolution by immuno-
electron microscopy (Fig. 1 C), VAMP.Aq immunoreactivity
was highly enriched in 61 of 148 (41.2%;
 
 n 
 
 
 
 11 cells) vesicles
 
colabeled for insulin (Fig. 1 C). Analyzed by single labeling for
VAMP.Aq, staining of the ER, Golgi apparatus, and small syn-
aptic-like microvesicles (Reetz et al., 1991) was very low, while
reactivity was also present on the plasma membrane and in en-
dosomes (see the legend to Fig. 1 and Discussion).
 
Reconstitution and calibration of secretory vesicle and 
ER-targeted aequorins
 
Given the high total Ca
 
2
 
 
 
 content of secretory vesicles (Hut-
ton et al., 1983), we used the approach adopted previously
to measure Ca
 
2
 
 
 
 in the ER lumen (Montero et al., 1995).
Apoaequorin was reconstituted at a low free Ca
 
2
 
 
 
 concentra-
tion (Montero et al., 1995), achieved by depleting cells of
Ca
 
2
 
 
 
 (Materials and methods). Depletion of vesicle Ca
 
2
 
 
 
had no marked effect on glucose or K
 
 
 
-stimulated insulin
secretion, or on vesicle motility (Pouli et al., 1998b; Tsuboi
et al., 2000; unpublished data).
To determine the response of the expressed aequorins to
Ca
 
2
 
 
 
 in situ, permeabilized cells were incubated at buffered
Figure 1. Localization of VAMP.Aq. (A) Schematic map of 
VAMP.Aq. VAMP2 and aequorin cDNAs were fused via an HA1 
epitope tag linker (Materials and methods) in order to localize 
mutated aequorin to the secretory vesicle lumen. (B) Confocal 
immunolocalization of VAMP.Aq. MIN6 cells were transfected with 
VAMP.Aq and stained with (a) mouse anti-HA1 monoclonal anti-
body (1:200) and (b) guinea pig antiinsulin antibody (1:150). 
(c) Extent of colocalization. (C) Immunoelectron microscopic local-
ization of insulin (15-nm gold) or VAMP.Aq (anti-HA tag, 10-nm 
gold). Morphometric analysis of separate sections from 10 singly 
labeled cells revealed the following distribution of anti-HA gold 
particles: dense core vesicles, 36; ER, 2; Golgi apparatus, 0; plasma 
membrane, 16; endosomes, 19.Free [Ca
2 ] in insulin secretory vesicles | Mitchell et al. 43
Ca
2  concentrations in the presence of ionomycin and mo-
nensin (Fig. 2, C and E). The sensitivity to Ca
2  (at pH 7.0)
of the VAMP.Aq chimaera was similar to that reported previ-
ously for mutant (D
119A) aequorin (Montero et al., 1995).
Intravesicular pH in intact cells was determined using a fu-
sion construct between VAMP2 and a mutated, pH-sensitive
GFP (pH.fluorin(e); Miesenbock et al., 1998), and gave a pH
value of 6.3   0.02 (n   85 cells; Fig. 2 A). Confirming that
this low intravesicular pH was unlikely to significantly affect
VAMP.Aq, near identical calibration data were obtained at
pH 5.7 (unpublished data). Therefore, we used the constants
obtained in vitro (Montero et al., 1995) to calculate [Ca
2 ]
from the fractional rate of aequorin consumption (F) accord-
ing to: [Ca
2 ]   1.44 10
(LOG[F] 3.4) (Rutter et al., 1993).
Dynamic measurement of secretory vesicle and ER 
Ca
2  concentrations
To monitor uptake of Ca
2  into vesicles in living cells, we
provoked rapid Ca
2  influx into cells through store-operated
channels (Parekh and Penner, 1997). During reintroduction
Figure 2. Measurement of intravesicular pH (A) and Ca
2  with 
cytosolic aequorin (B), VAMP.Aq (C and D), and ER.Aq (E and F). 
(A) Confocal images were acquired from cells transfected with 
pH.fluorin(e) (Miesenbock et al., 1998), maintained initially in KRB, 
pH 7.4, before digitonin-permeabilization and exchange into IB at 
the specified pH values, and buffered with morpholinosulphonic 
acid, Hepes, or TRIS (10 mM), plus 10  M ionomycin, 10  M mo-
nensin, and 1  M FCCP. Normalized fluorescence ratios before 
permeabilization were in the range of 0.16–0.18 (arrow); data were 
fitted using the Graph Pad Prism
TM. (C and E) After Ca
2  depletion 
and aequorin reconstitution, transfected cells were permeabilized 
with digitonin and perifused in the presence of ionomycin, mon-
ensin, and CPA (10  M each) with N-(2-hydroxyethyl)ethylene di-
amine triacetate (HEDTA)-buffered Ca
2  solutions at 0.5 mM calcu-
lated free Mg
2 . Cells expressing either (B) cytosolic aequorin, (D) 
VAMP.Aq, or (F) ER.Aq were perifused with KRB, supplemented 
with 1 mM EGTA (KRB/EGTA) and, where indicated, EGTA was 
replaced with 1.5 mM CaCl2. Cells were finally lysed in Ca
2 -rich 
hypotonic medium (10 mM CaCl2, 0.1 mM digitonin) for calibration 
(see Materials and methods and Results). The background count 
rate ( 1,200 cps; D and F) was identical during perifusion of 
untransfected cells and is due to autooxidation of coelenterazine n.
Figure 3. Ca
2  uptake into secretory vesicles (A–C) or ER (D and 
E). After Ca
2  depletion and aequorin reconstitution, cells were 
permeabilized with 20  M digitonin in IB; (A and D; see Materials 
and methods). Cells were perifused initially at  10
 9 M free [Ca
2 ] 
(buffered with 0.2 mM EGTA, 1 mM HEDTA; free [Mg
2 ]   0.5 mM) 
and then at 400 nM free [Ca
2 ], as indicated. Where present (closed 
symbols) ATP was 1 mM. Note that accumulation of Ca
2  at zero 
ATP is likely to be due to synthesis of small amounts of ATP by mito-
chondria. (B) Dose–response for the inhibition of vesicular [Ca
2 ] in-
creases by orthovanadate. Cells expressing VAMP.Aq were perme-
abilized and perifused at 400 nM Ca
2  in the presence of 1 mM ATP, 
plus the indicated concentrations of NaVO4. The initial rates of 
[Ca
2 ]SV increase upon the stepped increase in perifusate-free [Ca
2 ] 
from  1 to 400 nM were calculated by fitting time course data to a 
simple first order rate equation by nonlinear regression analysis 
(Microsoft Excel
TM). (C and E) After Ca
2  depletion and aequorin
reconstitution, Ca
2  uptake into intact cells was initiated by replac-
ing KRB containing 1 mM EGTA with EGTA-free KRB at 1.5 mM 
CaCl2, as indicated. Closed symbols, cells were incubated with 
thapsigargin (TG; 1  M) during the final 10 min of reconstitution, 
and the perifusion medium was supplemented with CPA (10  M). 
Data are representative of three separate experiments in each case.44 The Journal of Cell Biology | Volume 155, Number 1, 2001
of CaCl2 to cells previously perifused in EGTA, [Ca
2 ]c ap-
proached 500 nM, then fell back to 150–200 nM (Fig. 2 B).
By contrast, steady state free [Ca
2 ] in the secretory vesicle
matrix was 30–90  M (51; 7.5  M; n   5 separate cultures;
Fig. 2 D), whereas free [Ca
2 ] in the ER lumen was fivefold
higher (249; 12.9  M; n   3 preparations; Fig. 2 F).
Pathways of Ca
2  uptake into dense core 
secretory vesicles
Both the rate and extent of the [Ca
2 ] increases in the secre-
tory vesicles and the ER were strongly dependent on the
presence of added ATP in permeabilized cells (Fig. 3, A and
D). The increase in [Ca
2 ]SV upon reintroduction of Ca
2 
ions was completely inhibited by the P-type Ca
2  pump in-
hibitor, orthovanadatate, at  100  M (Fig. 3 B), but was
insensitive to 10  M orthovanadatate, a concentration
which strongly inhibits the plasma membrane Ca
2 -ATPase
(Carafoli, 1991). Preincubation with the specific SERCA in-
hibitor, thapsigargin (Thastrup, 1990), and perifusion with
cyclopiazonic acid (CPA) (Mason et al., 1991) had no effect
on the changes in [Ca
2 ]SV (Fig. 3 C and Table I), but mark-
edly ( 85%) inhibited ER [Ca
2 ] increases (Fig. 3 E).
Arguing against vesicular Ca
2  uptake via Ca
2 /H
  ex-
change, monensin, an Na
 /H
  exchanger, had no effect
on [Ca
2 ]SV increases in permeabilized cells (Fig. 4 A).
Similarly, ionomycin (a Ca
2 /H
  exchanger) decreased
[Ca
2 ]SV marginally ( 20%; Fig. 4 B), which is consistent
with the inability of this ionophore to bind to and trans-
port Ca
2  against a prevailing H
  gradient, but caused a
rapid and complete decline in [Ca
2 ]SV in the additional
presence of monensin (Fig. 4 B). Neither the vacuolar H
 -
ATPase inhibitor, bafilomycin (Fig. 4, C and D), nor
the protonophore carbonyl cyanide-p-trifluoromethoxy-
phenylhydrazone (FCCP), had any effect on vesicular Ca
2 
uptake (Fig. 4 E).
[Ca
2 ]SV increases were also completely unaffected by rais-
ing [Na
 ] from 0, 2, or 140 mM (Fig. 4 F), and by simulta-
neous blockade of Na
 /Ca
2  exchange and Ca
2 /H
  ex-
change (zero Na
 , 300 nM bafilomycin; unpublished data).
Effects of IP3 on [Ca
2 ]SV and [Ca
2 ]ER
To achieve large changes in intracellular IP3 levels, we coex-
pressed the metabotropic glutamate receptor, mGluR5, with
VAMP.Aq or ER.Aq. Stimulation of mGluR5-transfected
cells with the specific agonist, (S)-3,5-dihydroxyphenylgly-
cine (DHPG) (Thomas et al., 2000) caused a significant de-
Table I. Kinetic paramers for Ca
2  uptake into the ER versus 
secretory vesicles
Steady state [Ca
2 ]   SE t1/2   SE Kinitial n
 Ms  M/s
ER 249   12.9 5.7   0.2 29.8   0.8 3
 Thap 71   12.3 6.1   1.3 9.2   2.7
a 3
Vesicles 51   7.5 4.2   0.1 7.1   1.1 5
 Thap 40   4.4 3.9   0.6 7.4   0.5 3
Kinetic values were calculated by fitting time course data (Fig. 3) to a
simple first order exponential curve by nonlinear least squares regression
(Microsoft Excel™).
aP   1%.
Figure 4. Effects of collapse of H
  and Na
  gradients 
on vesicular Ca
2  accumulation in permeabilized 
cells. Cells were Ca
2  depleted and aequorin 
reconstituted with coelenterazine n before digitonin 
permeabilization. Cells were perifused in IB (Materials 
and methods) and free [Ca
2 ] was increased from  1 
to 400 nM as indicated, either in the absence (A, C, E, 
and F, open symbols) or in the presence of the 
additions (closed symbols) as follows: A, 10  M 
monensin; B, when indicated, 10  M ionomycin 
(triangles), or ionomycin plus 10  M monensin 
(circles); C, 300 nM bafilomycin; E, 1  M carbonyl 
cyanide-p-trifluoromethoxyphenylhydrazone (FCCP); 
F, 140 mM NaCl. Trace (D) shows the effect of bafilo-
mycin on vesicular acridine orange fluorescence in 10 
individual cells imaged simultaneously (Materials and 
methods). Data are representative of at least three 
separate experiments or are the means   SEM 
of three (B).Free [Ca
2 ] in insulin secretory vesicles | Mitchell et al. 45
crease in [Ca
2 ]ER (Fig. 5 E), but an increase in [Ca
2 ]SV
(Fig. 5 A). DHPG had no significant effect on the distribu-
tion of vesicles (imaged after expression of VAMP.GFP/pH-
fluorin (r); Fig. 5 D), indicating that enhanced exocytosis
and exposure of the VAMP.Aq to the extracellular medium
was unlikely to contribute to the observed increases in
[Ca
2 ]SV (Fig. 5 A, and see Discussion).
Similarly, in permeabilized cells, IP3 had no effect on
[Ca
2 ]SV (Fig. 5, B and C), while causing a large decrease in
[Ca
2 ]ER (Fig. 5, F and G).
RyR activation decreases [Ca
2 ]SV and [Ca
2 ]ER
The RyR agonists caffeine or 4-chloro-3-ethylphenol (4-
CEP) (Zorzato et al., 1993) provoked rapid decreases in
[Ca
2 ]SV and [Ca
2 ]ER (Fig. 6, A and C) in intact cells. Simi-
larly, cADPr (Galione, 1994) caused clear decreases in both
parameters in permeabilized cells (Fig. 6, B and D), and the
effects of cADPr were strongly potentiated by palmitoyl
CoA (Fig. 6, B and D), a coagonist of RyRs (Chini and
Dousa, 1996).
4-CEP mobilizes Ca
2  from an acidic, CPA-insensitive 
store in fura-2–loaded MIN6 cells
The above results suggested that activation of RyR on vesi-
cles should cause an increase in cytoplasmic [Ca
2 ]c, even af-
ter the depletion of the ER Ca
2  pool. Added to fura-2–
loaded MIN6 cells, 4-CEP caused a substantial increase in
[Ca
2 ]c in the absence of external Ca
2  (Fig. 7 A). This
[Ca
2 ]c increase was partly retained after depletion of
SERCA-dependent stores, giving a peak [Ca
2 ]c increase of
30–40% of that in control cells (Fig. 7 B versus A). The
[Ca
2 ]c increase elicited by 4-CEP was also partially retained
after treatment of cells with ionomycin (Fig. 7 C), but com-
pletely abolished after treatment with ionomycin plus mon-
ensin, to deplete acidic Ca
2  stores (Fig. 7 D). Demonstrat-
ing that the effects of 4-CEP on [Ca
2 ]SV were likely
mediated by RyR, immunoreactivity to these channels was
revealed on vesicle membranes by direct immunoelectron
microscopy (Fig. 7 E).
Effects of nutrient secretagogues on [Ca
2 ]ER 
and [Ca
2 ]SV
Exposure of islet  - or MIN6 cells to glucose or other nutri-
ents causes an increase in intracellular-free [ATP] (Kennedy
et al., 1999) closure of ATP-sensitive K
  (KATP) channels
(Bryan and AguilarBryan, 1997) and Ca
2  entry via voltage-
sensitive (L-type) Ca
2  channels (Safayhi et al., 1997).
High (20 mM) glucose, or a combination of nutrient
secretagogues (Ashcroft and Ashcroft, 1992), caused a large
increase in steady state [Ca
2 ] both in the ER and in vesi-
cles (Fig. 8, A and C), with no significant change in vesicu-
lar distribution (Fig. 8 B), which is consistent with the
increases in [Ca
2 ]c seen under these conditions (Grapen-
giesser et al., 1988).
Figure 5. Effect of IP3 on [Ca
2 ]SV and [Ca
2 ]ER in 
intact (A and E) and permeabilized (B, C, F, and G) 
cells. MIN6 cells were cotransfected with (A) 
VAMP.Aq or (E) ER.Aq plus a plasmid bearing 
mGluR5 cDNA. After the depletion of intracellular 
Ca
2  stores and aequorin reconstitution, cells were 
perifused in KRB, which initially contained 1 mM 
EGTA. Where indicated, EGTA was replaced with 1.5 
mM CaCl2. After the achievement of steady state 
[Ca
2 ], cells were challenged with the mGluR5 recep-
tor agonist DHPG (30  M) as indicated. Data are 
means of five independent experiments. (B, C, F, and 
G) Cells transfected with plasmids encoding VAMP.Aq 
(B and C) or ER.Aq (F and G) were Ca
2  depleted and 
aequorin was reconstituted before permeabilization 
and perifusion in IB buffer which initially contained 
0.1 mM EGTA (free [Ca
2 ]  1 nM). HEDTA and CaCl2 
were added to give a calculated free [Ca
2 ] of 200 
nM, as indicated. After the achievement of steady state 
[Ca
2 ]SV or [Ca
2 ]ER, IP3 (5  M) was introduced (filled 
symbols) as shown (B and F). Mean steady state 
[Ca
2 ]SV and [Ca
2 ]ER in three separate experiments in 
the presence or absence of IP3 are shown in C and G, 
respectively. Double asterisk indicates P   1% for the 
effect of IP3 on [Ca
2 ]ER. D shows cells cotransfected 
with VAMP.GFP (pH.fluorin(r); Miesenbock et al., 
1998) and mGluR5 cDNAs and depleted of Ca
2 , as 
in A. Localization of vesicles (a) after 1 h of Ca
2 -
depletion, (b) 120 s after readdition of CaCl2, and (c) 
60 s after DHPG addition.46 The Journal of Cell Biology | Volume 155, Number 1, 2001
Discussion
Aequorin as a reporter of secretory vesicle–free 
Ca
2  concentration
We show here that aequorin can be targeted to the lumen of
dense core secretory vesicles in living cells, with no incorpo-
ration into the ER, Golgi, or trans-Golgi network using the
cell’s own protein-sorting machinery (Fig. 1). However, a
proportion of VAMP.Aq was also present on the plasma
membrane and endosomes (Fig. 1 C). Since our recordings
were made at either high (1.5 mM, intact cells) or low (400
nM, permeabilized cells) external Ca
2  concentrations, the
plasma membrane–located photoprotein should be either
rapidly exhausted, or inactive, respectively. In any case, it
would appear that plasma membrane–targeted aequorin is
not reconstituted, since we would have expected to see a
“spike” of luminescence upon readdition of high Ca
2  con-
centrations to intact cells (e.g., Fig. 3 C). None was seen,
suggesting that the mistargeted protein may be inactivated
by unknown mechanisms during recycling between the
plasma membrane and endosomes.
Similarly, endosomal aequorin is likely to be inactive un-
der our conditions, since (a) the total endosomal Ca
2  con-
tent is low in neuroendocrine cells (Pezzati et al., 1997) and
(b) free [Ca
2 ] is particularly low ( 3.0  M) in acidic endo-
somes (Gerasimenko et al., 1998); active VAMP.Aq was lo-
Figure 6. Effect of RyR agonists on secretory vesicle 
and ER Ca
2  concentrations. Cells were transfected
(A and C) or infected with adenoviruses (B and D) 
encoding either VAMP.Aq (A and B) or ER.Aq (C and 
D), then perifused in KRB containing 1 mM EGTA (A 
and C) or digitonin permeabilized and perifused with 
IB which initially contained 0.1 mM EGTA (B and D). 
Replacement of EGTA with 1.5 mM CaCl2 (intact 
cells, A and C), or an increase in perifusate-free [Ca
2 ] 
to 200 nM (permeabilized cells, B and D), as indi-
cated. Other additions were: caffeine, 10 mM; 
4-CEP, 500  M; cADPr, 5  M; palmitoyl CoA, 50  M.
carbachol, which caused a large increase in [Ca
2 ]c in untreated 
cells (unpublished data). In C, CPA and ionomycin (10  M each) 
were added as indicated. Panel D was as C, but with the further 
addition of monensin (mon, 10  M) to the perifusate. Data are the 
means (  SEM) on observations on a total of (A) 58, (B) 35, (C) 28, 
and (D) 40 single cells, imaged in 3–5 separate experiments.
(E) Immunoelectron microscopic localization of RyR (arrows) on 
dense core vesicles.
Figure 7. Effect of caffeine and 4-CEP on cytosolic [Ca
2 ]. (A–D) 
Cells were loaded with fura-2 and imaged as described (Materials 
and methods). Where indicated (B–D), cells were preincubated with 
1  M thapsigargin in Ca
2 -free KRB (supplemented with 1 mM 
EGTA for 10 min) and then subsequently perifused in Ca
2 -free 
medium, initially in the absence of thapsigargin or other additions. 
Trace (A) shows the effect of 500  M 4-CEP, added as indicated, on 
[Ca
2 ]c in cells untreated with thapsigargin, and (B) the effect of the 
drug on cells treated with thapsigargin and subsequently perifused 
in the presence of 10  M CPA. Note the abolition of the response to Free [Ca
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cated exclusively in an acidic compartment (Fig. 4 B). Simu-
lation of the contribution of endosomal VAMP.Aq reveals
that our measurements may slightly underestimate [Ca
2 ]SV
(by  10%; unpublished data).
Mutated aequorins respond well to Ca
2  concentrations
over the range (30–90  M) which pertains within the secre-
tory vesicle, as well as the rest of the secretory pathway
(200–300  M) (Montero et al., 1997; Pinton et al., 1998),
without significant interference from the low pH environ-
ment. This feature of aequorin contrasts with GFP-based
Ca
2  probes (Miyawaki et al., 1997; Baird et al., 1999; Em-
manouilidou et al., 1999), whose fluorescence is strongly re-
duced at acidic pHs (Miesenbock et al., 1998; Fig. 2 E).
Thus, aequorin may represent the most suitable molecularly
targetable Ca
2  reporter presently available for the secretory
vesicle interior.
Free Ca
2  concentration in the secretory vesicle lumen
Despite possessing a larger total Ca
2  content (Andersson et
al., 1982; Hutton et al., 1983; Nicaise et al., 1992), se-
cretory vesicles displayed a significantly lower free [Ca
2 ]
than the ER or Golgi apparatus. Our measured values for
[Ca
2 ]SV ( 50  M) correspond fairly well to measurements
using other techniques in isolated chromaffin granules
(Krieger-Brauer and Gratzl, 1982; 24  M; null point titra-
tion), respiratory tract goblet cells (24  M; calcium orange 5
N fluorescence; Nguyen et al., 1998) and platelet  -granules
(12  M; null point titration; Grinstein et al., 1983). Thus,
free Ca
2  represents  0.05% of the total vesicular calcium
content of  -cell secretory vesicles (assuming a total Ca
2 
concentration of 50–100 mM; Hutton et al., 1983). Secre-
tory vesicles appear to have the highest Ca
2 -buffering ca-
pacity of all subcellular organelles so far examined, with the
percentage of free Ca
2  being much higher both in the cyto-
sol ( 2%) and in the ER ( 10%; Pozzan et al., 1994). Im-
portantly, resting [Ca
2 ]SV was well below the KM for Ca
2 
of proinsulin-processing enzymes (Davidson et al., 1988).
The identity of the Ca
2  binding proteins (or other mole-
cules) responsible for chelating free Ca
2  in these vesicles is
unknown. Chromogranins (Yoo and Albanesi, 1990), or the
mammalian homologue of Tetrahymena thermophila granule
lattice protein 1 (Grlp1) (Chilcoat et al., 1996), are each
strong possibilities. In addition, Ca
2  chelation by small
molecules, such as ATP (Hutton et al., 1983), may also be
involved. Finally, it is likely that in islet  -cells the insulin
crystal itself also participates in chelating vesicular Ca
2 
(Palmieri et al., 1988; see below).
Uptake of Ca
2  into secretory vesicles
The dense core secretory vesicle pool of islet  -cells has pre-
viously been considered relatively inert (Howell et al., 1975;
Prentki et al., 1984). We provide evidence here that net up-
take of Ca
2  into the dense core secretory vesicle population
occurs during activated Ca
2  influx (Figs. 2 and 3), and in
response to a receptor agonist (Fig. 5) or to nutrients (Fig.
8). However, and as discussed below (see also Fig. 9), these
measurements do not exclude the possibility that discrete
vesicle pools may experience different [Ca
2 ]SV changes.
We considered the possibility that the increases in
[Ca
2 ]SV observed upon challenge of cells with agonists (Fig.
5) or nutrients (Fig. 8) may be due in part to the activation
of exocytosis, and thus the exposure of aequorin within the
vesicle matrix to the extracellular Ca
2  concentrations (1.5
mM). However, this phenomenon is likely to contribute
negligibly to the observed signals, since only a tiny fraction
of the total vesicle population (the “primed” pool) in  -cells
(5–20/13,000 per min; Rorsman, 1997) undergoes fusion,
Figure 8. Effect of nutrient secretagogues on steady state [Ca
2 ] 
in secretory vesicles and the ER. Ca
2  depletion, and aequorin 
reconstitution, were carried out as described in Fig. 3 before expo-
sure of cells expressing VAMP.Aq (A) or ER.Aq (C) to the concentra-
tions of nutrients shown for 2 min in complete KRB medium 
containing 1.5 mM CaCl2. Mixed nutrients, 20 mM glucose, 10 mM 
glutamine, 10 mM leucine. In all cases, cells were preperifused for 
5 min and maintained in the presence of 1 mM 3-isobutyl-1-
methylxanthine (IBMX). Asterisk indicates P   5%; double asterisk 
indicates P   1% for the effect of 20 mM glucose or mixed nutri-
ents, respectively. In B, cells expressing VAMP.GFP (pH.fluorin(e)) 
were Ca
2  depleted as in A, before (a and c) or after (b and d) 
reintroduction of CaCl2 in the presence of 3 mM (a and b) or 30 mM 
(c and d) glucose. Bar, 5  m.48 The Journal of Cell Biology | Volume 155, Number 1, 2001
even during the maximal stimulation of exocytosis. Consis-
tent with this, we could detect no significant net movement
of VAMP.GFP fluorescence to the plasma membrane after
stimulation with DHPG (Fig. 5 D) or nutrients (Fig. 8 B).
Changes in intravesicular Ca
2  concentration detected
with vesicle-targeted aequorin seem likely to result largely
from the flux of Ca
2  ions across the vesicle membrane.
However, two caveats are important: (a) Ca
2  release from/
association with binding sites (or a “polyanionic matrix”)
(Nguyen et al., 1998) within the vesicle may also occur, es-
pecially if the intravesicular concentrations of other ions
(e.g., K
 ) change; (b) the number of Ca
2  ions that are
transported is unknown, since this depends on the binding
to intraorganellar sites. As discussed above, the present stud-
ies demonstrate that the ratio of free to bound Ca
2  within
the secretory vesicles is much lower than that in the ER or
Golgi lumen. This would appear at first to suggest that
changes in intravesicular Ca
2  concentration must involve
the flux of a very large number of Ca
2  ions. However, an al-
ternative possibility is that there are two (or more) pools of
bound Ca
2  in the secretory vesicle, one (the larger) com-
prising Ca
2  which is tightly bound (perhaps to a structural
component such as the insulin crystal) and the other a more
loosely bound and readily exchangeable pool. Depletion of
this latter, “labile” pool, may thus lead to a substantial de-
crease in the free vesicular [Ca
2 ], while involving the release
into the cytosol of relatively few Ca
2  ions.
The present data suggest that Ca
2  accumulation into ves-
icles is catalyzed at physiological [Ca
2 ]c chiefly by a P-type
Ca
2 -ATPase. Previous studies have indicated that transport
of Ca
2  into the Golgi apparatus is mediated partly by a
SERCA pump, and partly by another, unidentified thapsi-
gargin-insensitive system (Pinton et al., 1998). This second
ATP-dependent Ca
2  uptake system may be closely related
to ATP2C1 (Hu et al., 2000), the mammalian homologue
of the yeast Golgi Ca
2  transport ATPase, PMR1 (Sorin et
al., 1997). Supporting this view, mRNA-encoding ATP2C1
is abundant in MIN6 cells, and polyclonal antibodies raised
to ATP2C1 reveal a punctate pattern of intracellular stain-
ing (unpublished data). Intriguingly, although patients de-
fective in the ATP2C1 gene develop skin lesions (“Hailey-
Hailey” disease; Hu et al., 2000), it is unclear whether these
individuals also tend to suffer from neuroendocrine or other
disorders (e.g., diabetes mellitus).
Secretory vesicles are an IP3-insensitive, but 
caffeine/cADPr-sensitive Ca
2  store
The present results suggest that IP3 is unlikely to stimulate
the release of Ca
2  from dense core secretory vesicles directly
(Fig. 5).
By contrast, we now show (Figs. 6 and 7) that functional
RyR channels are present on the dense core vesicle mem-
brane of MIN6 cells. Type II RyR mRNA is present in ob/ob
mouse islets, mouse  -TC3 cells (Islam et al., 1998), and in
rat islets (Holz et al., 1999). RyR II protein has been de-
tected in INS1  -cells (Gamberucci et al., 1999), and ryano-
dine binding sites revealed in human islets (Holz et al.,
1999), mouse islets and MIN6 cells (Varadi and Rutter,
2001). Evidence for functional RyRs on the ER INS-1
 -cells (Maechler et al., 1999) has also recently been pro-
vided. The present data indicate that dense core vesicles may
represent a large fraction ( 30%) of the total RyR–accessi-
ble Ca
2  pool in MIN6  -cells (Fig. 7 B). However, the pro-
portion of the total vesicular Ca
2  pool which is mobilizable
via RyR is small. Thus, the [Ca
2 ]c increases observed when
the total acidic Ca
2  pool was emptied with CPA, ionomy-
cin, and monensin (Fig. 7 D) were much larger than those
apparent when cells were treated with 4-CEP after CPA and
ionomycin (Fig. 7 C).
Role of cADPr in  -cells
In the present studies, cADPr caused an apparent release of
Ca
2  from both the ER and from the secretory vesicles in
permeabilized MIN6  -cells. Moreover, we have recently
observed (Varadi and Rutter, 2001) that photolysis of caged
cADPr increases [Ca
2 ]c in MIN6 cells. These findings were
surprising in light of earlier results using ob/ob mouse islets
(Islam et al., 1993) or INS-1  -cells (Rutter et al., 1994),
where cADPr was ineffective in permeabilized cells. How-
ever, it should be noted that the present studies may provide
greater sensitivity to small Ca
2  fluxes by measuring changes
in [Ca
2 ] inside the secretory vesicle or ER.
Figure 9. Scheme: redistribution of organellar Ca
2  in secretory 
cells in response to G protein–coupled receptors (e.g., acetyl 
choline, AcCh) or glucose. IP3 generated in response to AcCh 
releases Ca
2  from the endoplasmic reticulum and Golgi apparatus, 
leading to an increase in cytosolic [Ca
2 ] and uptake of Ca
2  into 
dense core secretory vesicles distant from the plasma membrane 
(deep vesicles). Vesicular Ca
2  uptake is catalyzed by an undefined 
Ca
2 -ATPase, with properties similar to PMR1/ATP2C1 (see Discus-
sion). Increases in blood glucose lead to (1) the uptake of the sugar 
via glucose transporters, (2) enhanced ATP synthesis and closure of 
ATP-sensitive K
  channels, and (3) Ca
2  influx through L-type Ca
2  
channels. The resultant increases in [Ca
2 ]c are likely to promote 
net Ca
2  uptake (reflecting the balance of uptake versus release) into 
vesicles distant from the cell surface (deep vesicles). For those vesi-
cles ( 0.5% of total; Rorsman, 1997) located close to the plasma 
membrane and primed for exocytosis (primed vesicles), larger local 
[Ca
2 ]c increases (e.g., at the mouth of activated plasma membrane 
Ca
2  channels; Neher, 1998) may activate vesicular RyRs and pro-
voke net Ca
2  release.Free [Ca
2 ] in insulin secretory vesicles | Mitchell et al. 49
Could changes in intracellular cADPr concentration play
a role in the regulation of insulin secretion as proposed by
Takasawa et al. (1993)? Supporting this view, mice homozy-
gous for inactivation of the CD38 (ADPribose cyclase) gene
display impaired glucose tolerance (Kato et al., 1999). How-
ever, no change in the islet cADPr content was observed by
others in response to acutely elevated glucose concentrations
in vitro (Scruel et al., 1998), suggesting further studies are
necessary.
Conclusions
Dense core secretory vesicles rapidly take up Ca
2  ions via
an ATP-dependent non-SERCA Ca
2  pump (see Scheme,
Fig. 9). Ca
2  accumulated into vesicles may later be released
via RyRs once these vesicles reach a high local Ca
2  concen-
tration beneath the plasma membrane (Neher, 1998) or
elsewhere in the cell. This release may further contribute to
the high local [Ca
2 ]c in the vicinity of the submembrane
vesicles (Emmanouilidou et al., 1999), and may be impor-
tant to trigger exocytosis (Scheenen et al., 1998).
Materials and methods
Materials
Cell culture reagents were obtained from GIBCO BRL or Sigma-Aldrich
and molecular biologicals from Roche Diagnostics. Fura-2 and cADPr
were from Sigma-Aldrich and IP3 was from Molecular Probes.
Construction of VAMP.Aq cDNA
VAMP2 cDNA was amplified by PCR using specific primers (forward: 5 -
AAG CTT ACC ATG TCG GCT ACC GCT GCC ACC-3 ; reverse: 5 -AAG
CTT AGT GCT GAA GTA AAC GAT GAT-3 , HindIII sites are underlined).
This fragment was then inserted upstream of the HindIII-EcoRI fragment
encoding HA1-tagged D
119-A aequorin (Kendall et al., 1992) in plasmid
pBS . Chimeric VAMP.Aq cDNA was shuttled as a NotI-XhoI fragment
into pcDNAI (Invitrogen; Fig. 1 A).
Construction of adenoviral VAMP.Aq and ER.Aq
ER.Aq (Montero et al., 1995) and VAMP.Aq cDNAs were transferred into
plasmid pShuttleCMV (He et al., 1998) as Kpn1-Xho1 and Xba1-HindIII
fragments, respectively. The resultant constructs were recombined with
vector pAdEasy-1, and viral particles were generated as described (Ains-
cow and Rutter, 2001).
Cell culture, transient transfection, and adenoviral infection
MIN6  -cells (Miyazaki et al., 1990; passages #20 and #30) were cultured
in DME, with additions as given previously (Ainscow and Rutter, 2001).
Cells cultured on 13 mm poly-L-lysine–coated coverslips were transfected
with VAMP.Aq or ER.Aq plasmid DNA (1  g) using Lipofectamine
(Promega) in Optimem I serum-free medium (GIBCO BRL), or infected
with adenoviruses as described (Ainscow and Rutter, 2001). The total
quantity of reconstituted aequorin was higher in cells transfected with
ER.Aq than VAMP.Aq cDNAs due to the inclusion in the former of intronic
regulatory elements. Thus, typical integrated counts/culture (Fig. 2) after
the expression of VAMP.Aq were 3   10
5 and 1.5   10
6 for conventional
and adenoviral expression, respectively, and 2   10
6 and 2   10
7 for
ER.Aq.
[Ca
2 ] measurement with expressed aequorins
Cells were Ca
2  depleted by incubation with ionomycin (10  M), the
SERCA inhibitor CPA (10  M; Mason et al., 1991; Pinton et al., 1998), and
monensin (10  M) in modified Krebs-Ringer bicarbonate buffer (KRB; 140
mM NaCl, 3.5 mM KCl, 0.5 mM NaH2PO4, 0.5 mM MgSO4, 3 mM glu-
cose, 10 mM Hepes, 2 mM NaHCO3, pH 7.4) supplemented with 1 mM
EGTA for 5 min at 4 C. Aequorin was reconstituted in 0.1 mM EGTA, 5
 M coelenterazine (cytosolic aequorin) or coelenterazine n (Shimomura et
al., 1993; VAMP.Aq, ER.Aq) for 1–2 h at 4 C.
Intact cells were perifused (2 mL/min
 1) with KRB plus additions as
stated (37 C) close to a photomultiplier tube (ThornEMI), and emitted light
was collected (one data point) with a photon-counting board (ThornEMI;
Cobbold and Rink, 1987). Where indicated, cells were permeabilized with
digitonin (20  M, 1 min at 22 C) and subsequently perifused in intracellu-
lar buffer (IB) (140 mM KCl, 10 mM NaCl, 1 mM KH2PO4, 5.5 mM glu-
cose, 2 mM MgSO4, 1 mM ATP, 2 mM Na
  succinate, 20 mM Hepes, pH
7.05) at 37 C.
[Ca
2 ] imaging with fura-2
Cells were loaded with 5  M fura-2-AM (Sigma-Aldrich) for 40 min (37 C)
in KRB plus 0.05% Pluronic F-127 (BASF). [Ca
2 ]c was monitored in single
cells at 37 C as described (Ainscow et al., 2000), using a Leica DM-IRBE
inverted microscope (40  objective), and a Hamamatsu C4742-995
charge-coupled device camera driven by OpenLab (Improvision) software.
Imaging acridine orange fluorescence
Permeabilized cells were loaded with 3  M acridine orange (Tsuboi et al.,
2000) before imaging (37 C) on a Leica DM-IRBE
TM inverted optics epi-
flurosecence microscope, at 493   10 excitation, 530 nm emission (filters
were from Chroma Techology).
Immunocytochemistry
48 h after transfection or infection, cells were fixed in 3.7% (vol/vol) para-
formaldehyde and probed with antibodies essentially as described (Pouli et
al., 1998a).
Immunoelectron microscopy
Gelatin-embedded, aldehyde-fixed cells were frozen in liquid nitrogen
and ultrathin cryosections were obtained with a Reichert-Jung Ultracut E.
Immunogold localization was performed as described (Confalonieri et al.,
2000). Sections were immunostained either with rabbit anti-HA antibody
(Sigma-Aldrich), or with a sheep anti-RyR antibody (Molecular Probes) fol-
lowed by 10-nm protein A-gold. For double labeling, anti-HA–labeled sec-
tions were incubated with 1% glutaraldehyde in 0.1 M Na2PO4, pH 7.0,
followed by incubation with a guinea pig antiinsulin antibody (Dako) and
15-nm protein A-gold. Sections were examined with a ZEISS EM 902 elec-
tron microscope. No labeling was detected in control sections (unpub-
lished data).
Confocal imaging
Cells were imaged at 37 C on a Leica SP2 confocal spectrophotometer,
(488 nm excitation) using a 100  oil immersion objective.
Other methods and statistics
Free [Ca
2 ] and [Mg
2 ] were calculated using “METLIG” (Rutter and Den-
ton, 1988). Data are presented as the mean   SEM for the number of ob-
servations given, and statistical significance calculated using Student’s t
test.
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